The Mauritius and Rodrigues Non-Communicable Disease (NCD) Study
1 other identifier
observational
39,082
1 country
1
Brief Summary
Mauritius is located in the southern Indian Ocean with a population of 1.3 million in 2023. Mauritius is a multiethnic nation with 68% South Asian, 27% African (Creole), 3% Chinese and 2% Franco Mauritians. Seven population-based cross-sectional surveys using standardised protocols were conducted between 1987 and 2021). The participation rate has been over 85% in each survey. At each survey, participants were interviewed about living conditions, lifestyle and health, and anthropometry and blood pressure were measured. Biochemistry including lipids and an oral glucose tolerance test (OGTT) were performed Electrocardiograms (ECG) were recorded in participants aged 35 years and older. Previous participants were followed up in 2007 and 92% were successfully traced. Studies with identical methodology have been performed on the neighbouring island Rodrigues where the majority of the population are Creoles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 1987
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 5, 1987
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 23, 2021
CompletedFirst Submitted
Initial submission to the registry
June 24, 2025
CompletedFirst Posted
Study publicly available on registry
July 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2050
ExpectedJuly 17, 2025
July 1, 2025
34.7 years
June 24, 2025
July 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality
According to household interviews, death certificates from central registers at Ministry of Health and Wellness. 1. Household interviews: "Is the participant alive? If dead, do you have a copy of the death certificate? When did the participant die?" 2. Central registers: Vital status, if dead, date and cause of death from death certificates" Combining 1 and 2 will give date and cause of death. Absolute numbers and mortality rates will be reported for all and in subgroups i.e. sex, age-strata, ethnicity.
Up to 20 years from the baseline survey
Secondary Outcomes (4)
Diabetes Mellitus
Up to 20 years from the baseline survey
Cardiovascular disease (CVD)
Up to 20 years from the baseline survey
Hypertension
Up to 20 years from the baseline survey
Obesity
Up to 20 years from the baseline survey
Study Arms (2)
Randomly selected population-based subjects from the population (Mauritius)
Seven cross-sectional studies were performed between 1987 and 2021 on mainland Mauritius
Randomly selected population-based subjects from the population (Rodrigues)
In parallell, six cross-sectional studies were performed between 1992 and 2022 on Rodrigues
Eligibility Criteria
Random samples from the Mauritian (including Rodrigues) aged 25 to 74 years
You may qualify if:
- Men and women
- Randomly selected population-based samples (details see below)
- Not living in the study area
- Age outside the age-range
- In detail:
- In 2004, a new study was performed, with similar methodology. In 2009, nine index clusters were chosen with one randomly selected from each of the nine districts in Mauritius. Then, two neighbouring clusters were chosen surrounding the index cluster to form a "super cluster." From this super cluster, one in three households was randomly selected and one adult per household was invited to participate.5 The same methodology was used in 2015 and in 2021 with new randomly chosen clusters forming "super cluster" as in 2009. In addition, a random sample from the 1998 survey was invited for a resurvey in 2015.
- Participation rate has been over 85% in each survey. No sampling weights were used.
- Same methodology was used in Rodrigues.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Umeå Universitylead
- Ministry of Health and Wellness, Mauritiuscollaborator
- University of Helsinkicollaborator
- Monash Universitycollaborator
- Imperial College Londoncollaborator
- Baker Heart and Diabetes Institutecollaborator
Study Sites (1)
Unknown Facility
Port Louis, Mauritius
Related Publications (1)
Soderberg S, Taki H, Kowlessur S, Shaw JE, Magliano DJ, Tamosiunas A, Alberti G, Zimmet P, Tuomilehto J. Trends in the prevalence of cardiovascular disease, defined as ECG abnormalities and/or self-reported events, in Mauritius between 1987 and 2021: analysis of data from seven large population-based surveys. BMJ Open. 2025 Jun 16;15(6):e087693. doi: 10.1136/bmjopen-2024-087693.
PMID: 40523792RESULT
Related Links
Biospecimen
Plasma samples from the last surveys (2021 an 2022) are stored locally in Mauritius
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Zimmet, Professor
Monash University
- PRINCIPAL INVESTIGATOR
George Alberti, Professor
Imperial College, London, UK
- PRINCIPAL INVESTIGATOR
Jaakko Tuomilehto, Professor
Helsinki University, Helsinki, Finland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 20 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, consultant
Study Record Dates
First Submitted
June 24, 2025
First Posted
July 2, 2025
Study Start
April 5, 1987
Primary Completion
November 23, 2021
Study Completion (Estimated)
December 31, 2050
Last Updated
July 17, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Available now
- Access Criteria
- Reasonable request approved by senior researchers within the study group, plus obtained ethical approval.
If you would like to use the data from the Mauritius study, you should contact the Section of Biobank and Registry Support (BRS) at Umeå University, Sweden for discussion: info.brs@umu.se. Before sharing of data, the application will be evaluated by senior researchers within the network. Ethical approval must be obtained.